BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 17853126)

  • 1. Distinguishing between neuropsychological malingering and exaggerated psychiatric symptoms in a neuropsychological setting.
    Ruocco AC; Swirsky-Sacchetti T; Chute DL; Mandel S; Platek SM; Zillmer EA
    Clin Neuropsychol; 2008 May; 22(3):547-64. PubMed ID: 17853126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between performances on neuropsychological symptom validity testing and the MCMI-III in patients with fibromyalgia.
    Brooks L; Johnson-Greene D; Lattie E; Ference T
    Clin Neuropsychol; 2012; 26(5):816-31. PubMed ID: 22420469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the appropriateness of multiple symptom validity indices in psychotic and non-psychotic psychiatric populations.
    Schroeder RW; Marshall PS
    Clin Neuropsychol; 2011 Apr; 25(3):437-53. PubMed ID: 21391153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validation of the test of memory malingering in a forensic psychiatric setting.
    Weinborn M; Orr T; Woods SP; Conover E; Feix J
    J Clin Exp Neuropsychol; 2003 Oct; 25(7):979-90. PubMed ID: 13680444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between Symptom Validity Test failure and scores on the MMPI-2-RF validity and substantive scales.
    Gervais RO; Wygant DB; Sellbom M; Ben-Porath YS
    J Pers Assess; 2011; 93(5):508-17. PubMed ID: 21859291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of WMT, CARB, and TOMM failure rates in non-head injury disability claimants.
    Gervais RO; Rohling ML; Green P; Ford W
    Arch Clin Neuropsychol; 2004 Jun; 19(4):475-87. PubMed ID: 15163449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of coaching on the verbal and nonverbal medical symptom validity tests.
    Weinborn M; Woods SP; Nulsen C; Leighton A
    Clin Neuropsychol; 2012; 26(5):832-49. PubMed ID: 22651892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification accuracy of the Millon Clinical Multiaxial Inventory-III modifier indices in the detection of malingering in traumatic brain injury.
    Aguerrevere LE; Greve KW; Bianchini KJ; Ord JS
    J Clin Exp Neuropsychol; 2011 Jun; 33(5):497-504. PubMed ID: 21424973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Albany Consistency Index for the Test of Memory Malingering.
    Gunner JH; Miele AS; Lynch JK; McCaffrey RJ
    Arch Clin Neuropsychol; 2012 Jan; 27(1):1-9. PubMed ID: 22107827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The malingering factor.
    Williams JM
    Arch Clin Neuropsychol; 2011 Apr; 26(3):280-5. PubMed ID: 21345930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation between symptom validity testing and MMPI-2 scores as a function of forensic evaluation context.
    Wygant DB; Sellbom M; Ben-Porath YS; Stafford KP; Freeman DB; Heilbronner RL
    Arch Clin Neuropsychol; 2007 May; 22(4):489-99. PubMed ID: 17350796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates of below-chance performance in forced-choice symptom validity tests.
    Greve KW; Binder LM; Bianchini KJ
    Clin Neuropsychol; 2009 Apr; 23(3):534-44. PubMed ID: 19221937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embedded symptom validity tests and overall neuropsychological test performance.
    Meyers JE; Volbrecht M; Axelrod BN; Reinsch-Boothby L
    Arch Clin Neuropsychol; 2011 Feb; 26(1):8-15. PubMed ID: 21242283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response validity in forensic neuropsychology: exploratory factor analytic evidence of distinct cognitive and psychological constructs.
    Nelson NW; Sweet JJ; Berry DT; Bryant FB; Granacher RP
    J Int Neuropsychol Soc; 2007 May; 13(3):440-9. PubMed ID: 17445293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of forensic and non-forensic adult psychiatric inpatients on the Test of Memory Malingering.
    Gierok SD; Dickson AL; Cole JA
    Arch Clin Neuropsychol; 2005 Aug; 20(6):755-60. PubMed ID: 15894456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the limits of effort testing: symptom validity tests and severity of neurocognitive symptoms in nonlitigant patients.
    Merten T; Bossink L; Schmand B
    J Clin Exp Neuropsychol; 2007 Apr; 29(3):308-18. PubMed ID: 17454351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test of memory malingering (TOMM) trial 1 as a screening measure for insufficient effort.
    O'Bryant SE; Engel LR; Kleiner JS; Vasterling JJ; Black FW
    Clin Neuropsychol; 2007 May; 21(3):511-21. PubMed ID: 17455034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of children on symptom validity tests: TOMM, MSVT, and FIT.
    Blaskewitz N; Merten T; Kathmann N
    Arch Clin Neuropsychol; 2008 Jul; 23(4):379-91. PubMed ID: 18337057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intelligence, memory and malingering: correlation between scales].
    Ramírez RM; Chirivella-Garrido J; Caballero MC; Ferri-Campos J; Noé-Sebastián E
    Rev Neurol; 2004 Jan 1-15; 38(1):28-33. PubMed ID: 14730487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Known-groups cross-validation of the letter memory test in a compensation-seeking mixed neurologic sample.
    Vagnini VL; Sollman MJ; Berry DT; Granacher RP; Clark JA; Burton R; O'Brien M; Bacon E; Saier J
    Clin Neuropsychol; 2006 Jun; 20(2):289-304. PubMed ID: 16690548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.